Suppr超能文献

意大利队列中类风湿关节炎相关间质性肺病“临床警示信号”的验证

Validation of "Clinical Red Flags" for RA-ILD in an Italian cohort.

作者信息

Cela Eneida, Bonini Chiara, Cavalli Francesco, Luciano Alessandra, Kroegler Barbara, Ora Josuel, Bergamini Alberto, Chiocchi Marcello, Rogliani Paola, Chimenti Maria Sole, Conigliaro Paola

机构信息

Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome "Tor Vergata", Rome, Italy.

Division of Respiratory Medicine, University Hospital Policlinico Tor Vergata, Rome, Italy.

出版信息

Front Med (Lausanne). 2025 Jul 16;12:1625742. doi: 10.3389/fmed.2025.1625742. eCollection 2025.

Abstract

INTRODUCTION

Rheumatoid arthritis (RA) is a systemic inflammatory disease, characterized by articular and extra-articular manifestations, including Interstitial Lung Disease (ILD). An early diagnosis of ILD can be essential in improving disease outcome. A clinical practice checklist has previously been proposed, highlighting red flags in signs and symptoms suggestive of RA-ILD. Our aim was to validate the "checklists of red flags signs or symptoms suggestive of RA-ILD" in our cohort of RA patients, by assessing the diagnostic utility of dyspnea, cough, and crackles, both individually and in combination.

METHODS

We performed a retrospective study including medical charts of consecutive RA patients fulfilling 2010 ACR/EULAR classification criteria. The diagnosis of RA-ILD was based on the chest HRCT exam. The primary symptoms and signs of ILD, namely cough, crackles, and dyspnea, were considered separately and in combination to determine diagnostic performance metrics.

RESULTS

Our cohort included 107 patients with RA, from which 55 (51.4%) with a diagnosis of RA-ILD. Female patients were predominant in both RA-ILD and No-ILD groups (56.4 and 82.6% respectively), with a significantly higher proportion in the latter ( = 0.0036). Dyspnea alone demonstrated a good diagnostic utility for RA-ILD with a sensitivity of 63.5% and specificity of 60%, PPV of 60% and an NPV of 63.5%, ( = 0.0203). Additionally, crackles exhibited the highest sensitivity among the individual symptoms (66.7%), a specificity of 57.4% and a significant association with RA-ILD ( = 0.0265). The presence of either dyspnea or crackles confirmed their strong association with RA-ILD ( = 0.0066), with the highest level of accuracy (63.5%) and specificity (63.8%). Also, the combination of cough or dyspnea was significantly associated with RA-ILD ( = 0.0111). A strong correlation was observed between RA-ILD and the presence of both crackles and dyspnea ( = 0.0351). When the three symptoms were combined, the sensitivity was 64.3%, the specificity was 53.2%, the PPV was 32.7%, and the NPV was 81%, but did not reach statistical significance ( = 0.1284).

CONCLUSION

Overall, crackles and dyspnea were the most significant markers of RA-ILD, both individually, and in combination. This study confirms that the red flags previously identified, especially in combination, show an important accuracy and reliability as clinical biomarkers in the early detection of RA-ILD.

摘要

引言

类风湿关节炎(RA)是一种全身性炎症性疾病,以关节和关节外表现为特征,包括间质性肺疾病(ILD)。ILD的早期诊断对于改善疾病预后至关重要。此前已提出一份临床实践清单,突出提示RA-ILD的体征和症状中的警示信号。我们的目的是通过评估呼吸困难、咳嗽和啰音单独及联合使用时的诊断效用,在我们的RA患者队列中验证“提示RA-ILD的警示信号体征或症状清单”。

方法

我们进行了一项回顾性研究,纳入符合2010年美国风湿病学会(ACR)/欧洲抗风湿病联盟(EULAR)分类标准的连续RA患者的病历。RA-ILD的诊断基于胸部高分辨率CT(HRCT)检查。分别单独及联合考虑ILD的主要症状和体征,即咳嗽、啰音和呼吸困难,以确定诊断性能指标。

结果

我们的队列包括107例RA患者,其中55例(51.4%)诊断为RA-ILD。女性患者在RA-ILD组和非ILD组中均占主导(分别为56.4%和82.6%),后者比例显著更高(P = 0.0036)。单独的呼吸困难对RA-ILD显示出良好的诊断效用,敏感性为63.5%,特异性为60%,阳性预测值(PPV)为60%,阴性预测值(NPV)为63.5%,(P = 0.0203)。此外,啰音在个体症状中表现出最高的敏感性(66.7%),特异性为57.4%,且与RA-ILD有显著关联(P = 0.0265)。呼吸困难或啰音的存在证实了它们与RA-ILD的强关联(P = 0.0066),具有最高水平的准确性(63.5%)和特异性(63.8%)。而且,咳嗽或呼吸困难的联合与RA-ILD有显著关联(P = 0.0111)。观察到RA-ILD与啰音和呼吸困难同时存在之间有很强的相关性(P = 0.0351)。当三种症状联合时,敏感性为64.3%,特异性为53.2%,PPV为32.7%,NPV为81%,但未达到统计学显著性(P = 0.1284)。

结论

总体而言,啰音和呼吸困难无论是单独还是联合,都是RA-ILD最显著的标志物。本研究证实,先前确定的警示信号,尤其是联合使用时,在RA-ILD的早期检测中作为临床生物标志物显示出重要的准确性和可靠性。

相似文献

1
Validation of "Clinical Red Flags" for RA-ILD in an Italian cohort.
Front Med (Lausanne). 2025 Jul 16;12:1625742. doi: 10.3389/fmed.2025.1625742. eCollection 2025.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

本文引用的文献

1
Navigating interstitial lung disease associated with rheumatoid arthritis (RA-ILD): from genetics to clinical landscape.
Front Med (Lausanne). 2025 Feb 24;12:1542400. doi: 10.3389/fmed.2025.1542400. eCollection 2025.
3
Alteration of telomere length and mtDNA copy number in interstitial lung disease associated with rheumatoid arthritis.
Autoimmunity. 2025 Dec;58(1):2473741. doi: 10.1080/08916934.2025.2473741. Epub 2025 Mar 4.
9
Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement.
Z Rheumatol. 2024 Mar;83(2):160-168. doi: 10.1007/s00393-023-01464-w. Epub 2024 Jan 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验